The idea of combining discrete-event simulation and system dynamics has been a topic of debate in the operations research community for over a decade. Many authors have considered the potential benefits of such an approach from a methodological or practical standpoint. However, despite numerous examples of models with both discrete and continuous parameters in the computer science and engineering literature, nobody in the OR field has yet succeeded in developing a genuinely hybrid approach which truly integrates the philosophical approach and technical merits of both DES and SD in a single model. In this paper we consider some of the reasons for this and describe two practical healthcare examples of combined DES/SD models, which nevertheless fall short of the “holy grail” which has been so widely discussed in the literature over the past decade.
28 September 2022 in International Journal of Physical Distribution & Logistics Management
Purpose: This paper links supply chain risk management to medicine supply chains to explore the role of policymakers in employing supply chain risk management strategies (SCRMS) to reduce generic medicine shortages.Design/methodology/approach: Using secondary data supplemented with primary data, the authors map and compare seven countries' SCRMS for handling shortage risks in their paracetamol supply chains before and during the first two waves of the COVID-19 pandemic.Findings: Consistent with recent research, the study finds that policymakers had implemented few SCRMS specifically for responding to disruptions caused by COVID-19. However, shortages were largely avoided since multiple strategies for coping with business-as-usual disruptions had been implemented prior to the pandemic. The authors did find that SCRMS implemented during COVID-19 were not always aligned with those implemented pre-pandemic. The authors also found that policymakers played both direct and indirect roles.Research limitations/implications: Combining longitudinal secondary data with interviews sheds light on how, regardless of the level of preparedness during normal times, SCRMS can be leveraged to avert shortages in abnormal times. However, the problem is highly complex, which warrants further research.Practical implications: Supply chain professionals and policymakers in the healthcare sector can use the findings when developing preparedness and response plans.Social implications: The insights developed can help policymakers improve the availability of high-volume generic medicines in (ab)normal times.Originality/value: The authors contribute to prior SCRM research in two ways. First, the authors operationalize SCRMS in the medicine supply chain context in (ab)normal times, thereby opening avenues for future research on SCRM in this context. Second, the authors develop insights on the role policymakers play and how they directly implement and indirectly influence the adoption of SCRMS. Based on the study findings, the authors develop a framework that captures the diverse roles of policymakers in SCRM.
This paper describes the process of developing a hybrid simulation model for a disease called age-related macular degeneration (AMD), a common cause of sight loss in people aged over 65. The model is implemented in the software AnyLogic, and combines discrete-event and agent-based simulation. Embedded in each agent there is also an individual compartmental model for disease progression. The overall aim of the hybrid model was to use the specific example of AMD to explore the wider links between the health and social care systems in the UK. We discuss the challenges of model development and the rationale for our modelling decisions, and reflect upon the advantages and disadvantages of using a hybrid model in this case.
Background: Stroke incidence rates have fallen in high-income countries over the last several decades, but findings regarding the trend over recent years have been mixed. The aim of the study was to describe and model temporal trends in incidence of stroke by age and sex between 2010 and 2015 in Norway, and to generate incidence projections towards year 2040.Methods: All recorded strokes in Norway between 2010 and 2015 were extracted from the National Patient Registry and the National Cause of Death Registry. We report incidence by age, sex, and year; in raw numbers, per 100,000 person-years, by WHO and European standard populations; and generated statistical models by stroke type, age, sex, and year; and projected stroke incidence toward year 2040.Results: The data covered 30.1 million person-years at risk, 53431 unique individuals hospitalized with a primary stroke diagnosis, and 6315 additional individuals registered as dead due to stroke. From 2010 to 2015, individuals suffering stroke per 100,000 person-years dropped from 239 to 195 (208 to 177 excluding immediate deaths). The decline was driven by ischemic strokes, with a statistically non-significant time trend for hemorrhagic stroke.Conclusions: The age-dependent incidence of ischemic strokes in Norway is declining rapidly, and more than compensates for the growth and ageing of the population. Comparisons with historic incidence statistics show that the reduction in incidence rates has accelerated over the last two decades.
Hybrid simulation, the combination of simulation paradigms to address a problem is becoming more popular as the problems we are presented with become more complex. This is evidenced by an increase in the number of hybrid papers published in specific domains and the number of hybrid simulation frameworks being produced across domains. This paper focuses on two hybrid simulation models from a healthcare context. The first uses system dynamics and discrete-event simulation and was developed using two separate software tools (Vensim and Simul8). The second uses agent-based and discrete-event simulation and was developed in a single software environment, Anylogic. The reflections on these models add to the debate about the viability of hybrid modelling and suggest future steps to support the take up of the approach.